| Date: | 07/16/2008 |
|---|---|
| Organization: | Department of Public Health |
| Regulatory Authority: |
MGL c.111, § 3 MGL c.111L |
| Official Version: | Purchase the official print version |
105 CMR 960.000 is set forth for the purpose of interpreting and implementing M.G.L. c.111L, Biotechnology, as enacted under Chapter 27 of the Acts of 2005, An Act Enhancing Regenerative Medicine in the Commonwealth.
Download a PDF copy of the regulation below.